Inhibitory effect of putranjivain A on allergic inflammation through suppression of mast cell activation
Authors:
- 1 February 2014
- journal article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 274 (3) , 455-461
Abstract
No abstract availableKeywords
Funding Information
- NRF
- Ministry of Science, ICT & Future Planning (2012M3A9B6055416)
This publication has 38 references indexed in Scilit:
- Structural requirements for the inhibition of calcium mobilization and mast cell activation by the pyrazole derivative BTP2The International Journal of Biochemistry & Cell Biology, 2011
- Chrysin suppresses mast cell-mediated allergic inflammation: Involvement of calcium, caspase-1 and nuclear factor-κBToxicology and Applied Pharmacology, 2011
- Sensitivity of NFAT Cycling to Cytosolic Calcium Concentration: Implications for Hypertrophic Signals in Cardiac MyocytesBiophysical Journal, 2009
- The development of allergic inflammationNature, 2008
- NFAT and NFκB Activation in T Lymphocytes: A Model of Differential Activation of Gene ExpressionAnnals of Biomedical Engineering, 2006
- Putranjivain A from Euphorbia jolkini inhibits proliferation of human breast adenocarcinoma MCF-7 cells via blocking cell cycle progression and inducing apoptosisToxicology and Applied Pharmacology, 2006
- Protein kinase Cδ functions downstream of Ca2+ mobilization in FcεRI signaling to degranulation in mast cellsJournal of Allergy and Clinical Immunology, 2004
- Investigations on the binding and antioxidant properties of the plant flavonoid fisetin in model biomembranesFEBS Letters, 2004
- Increased expression of histamine H1 receptor mRNA in allergic rhinitisClinical & Experimental Allergy, 1996
- Inhibitory Effects of Egyptian Folk Medicines on Human Immunodeficiency Virus(HIV) Reverse Transcriptase.Chemical and Pharmaceutical Bulletin, 1995